Haemonetics Corporation (HAE) is a Healthcare company in the Medical Devices industry. It has a market capitalization of $4.94B, a trailing price-to-earnings ratio of 21.7 and a free-cash-flow yield of 5.1%. Over the most recent reported fiscal year, revenue declined 2.0% and free cash flow per share grew 95.9%.